State guide · NY · prices checked Oct 3, 2026

GLP-1 in New York: prices and Medicaid coverage

As of Oct 3, 2026, the cheapest GLP-1 program that ships to New York is SnagRx at $69 a month, month to month, all in; 17 of the 21 partner programs we track ship there. New York Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.

Julian CaraulaniFounder, PriceTracker GLP-1Prices verified October 2026

Cheapest that ships to New York

$69/mo

at SnagRx, month to month, all in.

New York Medicaid, weight loss

Not covered for weight loss

As of January 2026, per KFF. Diabetes: covered in every state.

$69/mo at SnagRx on SnagRx’s site ↗See all 17 that ship to New York

On this page

Programs that ship to New York
Does New York Medicaid cover it?
New York Medicaid in numbers
Medicare in every state
Neighbouring states
Common questions
Sources

Which GLP-1 programs ship to New York?

17 of the 21 partner programs we track ship to New York, from $69 a month, month to month at SnagRx to $299 at Willow, all in.

Cheapest first by what leaves your account each month, membership fees included, then the shorter plan. Each is a telehealth program: a clinician licensed in New York reviews you online and a pharmacy mails the medication. Prices checked Oct 3, 2026.

Show all 17

State list not verified · These say how many states they serve but not which, so we cannot say whether they ship here: bmiMD (48 states), DudeMeds (46 states), TMates (45 states), SkinnyRx (48 states).

Program links pay us a commission. The order is the all-in monthly price, never what anyone pays us. How we earn.

Cheapest GLP-1 nationally Cheapest semaglutide Cheapest tirzepatide Compare every state

Does New York Medicaid cover GLP-1s for weight loss?

Not covered for weight loss

New York Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.

Weight loss

Not covered, January 2026

Type 2 diabetes

Required in every state

Heart risk, sleep apnea

Required (Wegovy, Zepbound)

Prior authorization

Typical when covered

Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. KFF counts coverage under fee-for-service; if your New York Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.

What may have changed since January

CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether New York Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.

The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.

How many GLP-1s does New York Medicaid pay for?

815,882 GLP-1 prescriptions in 2025, 3rd of the 50 states and DC, with $929.5 million reimbursed before rebates.

Prescriptions, 2025

815,882

3rd of 51

Medicaid paid

$929.5M

3rd of 51, before rebates

Per prescription

$1,139

$1,051 nationally

Weight-loss brands

0.0%

49th highest share of 51

Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.0% of New York Medicaid's GLP-1 prescriptions in 2025 (208). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea.

New York Medicaid GLP-1 prescriptions by brand, 2025
Brand	Prescriptions	Share	Medicaid paid
Ozempic	464,371	57%	$541.1 million
Mounjaro	218,864	27%	$232.3 million
Trulicity	103,672	13%	$120.5 million
Rybelsus	24,252	3.0%	$32.6 million
Liraglutide (generic)	3,391	0.4%	$1.9 million
Victoza	816	0.1%	$633,976

Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.

On Medicare in New York?

Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.

medicare.gov, read Oct 3, 2026: “You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

Check the Bridge rules Does Medicare cover GLP-1s?

New York and the states around it

Medicaid’s weight-loss answer (January 2026, KFF) and the partner programs that ship there, priced the same way as above.

State	Medicaid, weight loss	Ship there	Cheapest that ships there
New York	Not covered	17	$69/mo
Connecticut	Not covered	17	$69/moSnagRx
Massachusetts	Covered	17	$69/moSnagRx
New Jersey	Not covered	17	$69/moSnagRx
Pennsylvania	Not covered	17	$69/moSnagRx
Vermont	Not covered	17	$69/moSnagRx

All 50 states and DC

GLP-1s in New York: common questions

Does New York Medicaid cover Wegovy or Zepbound for weight loss?

Not as of January 2026: KFF found New York Medicaid did not cover GLP-1s for obesity under fee-for-service. Coverage for weight loss is optional for each state, so it can change; ask your plan, and see whether New York has joined the BALANCE model.

Does New York Medicaid cover Ozempic or Mounjaro for diabetes?

Yes. Weight-loss coverage is optional for states, but Medicaid must cover GLP-1s approved for type 2 diabetes, so Ozempic, Mounjaro and the others are covered for blood sugar in New York as in every state, usually behind prior authorization. Wegovy for heart risk and Zepbound for sleep apnea are required uses too (KFF).

Has New York Medicaid joined the BALANCE model?

We could not find a published list of the state Medicaid programs taking part, so we cannot say. BALANCE is a voluntary CMS model: states could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026 (KFF). It does not change what you pay, because federal law already limits Medicaid out-of-pocket costs to nominal amounts. Ask New York Medicaid whether it joined.

What is the cheapest GLP-1 program that ships to New York?

SnagRx, at $69 a month, month to month all in (membership included), checked Oct 8, 2026. Then Embody at $69 on a 12-month plan, and CoreAge Rx at $99, month to month. These are telehealth programs: a clinician licensed in New York reviews you online and a pharmacy mails the medication.

How many GLP-1 telehealth programs ship to New York?

17 of the 21 partner programs we track ship to New York on a state list we could verify. None of them names New York as a state it does not serve. 4 publish a state count without the list, so we cannot say: bmiMD, DudeMeds, TMates, SkinnyRx.

How many GLP-1 prescriptions did New York Medicaid pay for in 2025?

815,882, 3rd of the 50 states and DC, with $929.5 million reimbursed before rebates (CMS State Drug Utilization Data). Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.0% of those prescriptions.

Can I get a GLP-1 for $50 a month on Medicare in New York?

If you have Medicare Part D and meet the rules, yes. Medicare's temporary GLP-1 Bridge is the same in every state: medicare.gov says "This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)" and "You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)." (read Oct 3, 2026).

Sources

Program prices are read off each seller’s own page weekly; the last check behind this page was Oct 3, 2026. The Medicaid answer is KFF’s, quoted below with the day we read it, and is re-read monthly. The prescription figures are CMS’s.

KFF state map, the New York row

“New York,NY,Not covered”

https://datawrapper.dwcdn.net/GL0OB/8/dataset.csv · read Oct 8, 2026

KFF, published Jan 16, 2026

“13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF, what Medicaid must cover

“coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF, required uses besides diabetes

“for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound)”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF, prior authorization

“When covered, GLP-1s are typically subject to utilization controls such as prior authorization, which can further limit access.”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF on BALANCE, state rollout

“For state Medicaid agencies that opt to participate in the model, implementation will be on a rolling basis from May 1, 2026 through January 1, 2027.”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Oct 8, 2026

KFF on BALANCE, deadlines

“The date for manufacturers to notify CMS of their interest in participating was January 8, 2026; for Medicare Part D plans was April 20, 2026; and for state Medicaid programs is July 31, 2026”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Oct 8, 2026

KFF on BALANCE, what you pay

“The model will not affect out-of-pocket costs for Medicaid enrollees, which are limited to nominal amounts under federal law.”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Oct 8, 2026

Medicare, the GLP-1 Bridge

“This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)”

https://www.medicare.gov/coverage/weight-loss-drugs · read Oct 3, 2026

Medicare, the Bridge copay

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

https://www.medicare.gov/coverage/weight-loss-drugs · read Oct 3, 2026

CMS dataset

State Drug Utilization Data 2025, CMS State Drug Utilization Data, data.medicaid.gov

https://data.medicaid.gov/dataset/158a1baa-5506-400a-8ec3-97756f0b0536 · updated by CMS Jul 13, 2026

Full brief: KFF, Medicaid Coverage of and Spending on GLP-1s. Not insurance or medical advice: your plan and your prescriber decide.

$69/mo is New York's floor today. It moves.

One email when a program that ships to New York gets cheaper.

Every state